Default company panoramic image


OxyVits is a medically supported anti-oxidant vitamin cocktail clinically tested to yield improved health benefits over the long term.

  • Stage Full Product Ready
  • Industry Retailing / Distribution
  • Location Tucson, AZ, USA
  • Currency USD
  • Founded June 2010
  • Employees 50
  • Website

Company Summary

Our company has traditionally been involved in development of hedge fund strategies. However, we have branched out to the pharmaceutical industry as well as mining. Through these efforts we were able to finance OxyVits to serve the needs of consumers in the use of anti-oxidant supplements. The clients that we are approaching are primarily distributors and shops that specialize in this kind of sector.


  • Default avatar
    Abraham Jalbout

    Dr. Jalbout holds a PhD in Physics (at the age of 19) with management degrees. He has lead many successful industrial projects. Additionally from a scientific point of view Dr. Jalbout hold over 400 scientific publications, 3000 citations and several patent disclosures.

  • Default avatar
    Bang Xu

    Dr. Bang Xu graduated from East China University of Chemical Technology and received his PhD from the University of Arkansas in chemical engineering. He has over 30 years of experience in chemical engineering. Dr. Xu has also worked with large integrated majors including the world leader in GTL that is ConocoPhillips. The company Dr. Xu founded, Dason Technology has several multi-million dollar contracts from large Chinese corporations.

  • Default avatar
    Khaled Khan

    Dr. Khan serves as Chief Technology Officer for OxyVits and was previously medical director of the Intestine Transplant Program at the University of Arizona. He was also director of the Liver Transplant Program at the University of Arizona and specializes in the treatment of patients with short gut syndrome and liver failure induced by total parenteral nutrition. Currently, he is Professor of Surgery at Georgetown University.

  • Default avatar
    Horacio Rilo

    Dr. Rilo serves as Chief Medical Officer for OxyVits and holds appointments as Professor of Surgery, Director of the Center for Cellular Transplantation, and Associate Director of the Arizona Diabetes Center at The University of Arizona in Tucson, Arizona. Prior to this he was Professor of Medicine at the University of Chicago and the University of Pittsburg. Dr. Rilo holds over 150 cientific publications and multiple patents.

  • Default avatar
    Bolong Cao

    Dr. Cao was previously senior technology manager, licensing officer and technology manager for more than six years at the University of Washington Center for Commercialization. Prior to this he was the technical director of Business Development for Cerep, Inc. in Redmond, Washington, and director of technology assessment and licensing at Molecumetics, Ltd., Bellevue, Washington.


  • Default avatar
    Andrew A. Anissi